Sargent Bickham Lagudis LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.

Quarter-by-quarter ownership
Sargent Bickham Lagudis LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q4 2022$7,276
-9.0%
179
+38.8%
0.00%0.0%
Q3 2022$8,0000.0%1290.0%0.00%0.0%
Q2 2022$8,0000.0%1290.0%0.00%0.0%
Q1 2022$8,000
-20.0%
1290.0%0.00%0.0%
Q4 2021$10,000
+150.0%
129
+303.1%
0.00%
Q3 2021$4,000
-20.0%
320.0%0.00%
Q2 2021$5,000
+25.0%
320.0%0.00%
Q1 2021$4,000
-55.6%
32
-50.0%
0.00%
Q4 2020$9,000
+200.0%
64
+100.0%
0.00%
Q3 2020$3,000
+50.0%
320.0%0.00%
Q2 2020$2,000
+100.0%
320.0%0.00%
Q1 2020$1,000
-50.0%
320.0%0.00%
Q4 2019$2,000
+100.0%
320.0%0.00%
Q3 2019$1,000
-50.0%
320.0%0.00%
Q2 2019$2,000
+100.0%
320.0%0.00%
Q1 2019$1,0000.0%320.0%0.00%
Q4 2018$1,0000.0%320.0%0.00%
Q3 2018$1,000
-50.0%
320.0%0.00%
Q2 2018$2,000320.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 508,558$82,330,00027.28%
Valiant Capital Management, L.P. 307,700$49,814,0003.74%
NEA Management Company, LLC 1,590,002$257,405,0003.35%
NIA IMPACT ADVISORS, LLC 39,891$6,458,0003.15%
Ikarian Capital, LLC 200,000$32,379,0002.62%
Soleus Capital Management, L.P. 103,114$16,693,0002.57%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 157,334$25,471,0002.47%
Capital Impact Advisors, LLC 45,440$7,356,0002.37%
ARK Investment Management 7,776,119$1,258,876,0002.34%
Sassicaia Capital Advisers LLC 13,513$2,188,0002.28%
View complete list of CRISPR THERAPEUTICS AG shareholders